We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease (CD) research to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or Crohn’s disease (CD) (including associated symptoms such as weight loss, growth failure, cramps, frequent fevers and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
